z-logo
Premium
Angiopoietin 1, PDGF‐B, and TGF‐β gene regulation in endothelial cell and smooth muscle cell interaction
Author(s) -
Nishishita Toshishita,
Lin Pengnian Charles
Publication year - 2003
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.10718
Subject(s) - platelet derived growth factor receptor , microbiology and biotechnology , downregulation and upregulation , angiopoietin receptor , vascular smooth muscle , angiopoietin , stimulation , biology , mapk/erk pathway , signal transduction , pi3k/akt/mtor pathway , growth factor , chemistry , endocrinology , cancer research , receptor , gene , vascular endothelial growth factor , angiogenesis , smooth muscle , genetics , vegf receptors
The vascular wall is mainly composed of endothelial cells (ECs) and smooth muscle cells (SMCs). The crosstalking between these two cell types is critical in the vascular maturation process. Genetic studies suggest that the Tie2/angiopoietin 1 (Ang1) pathway regulates vascular remodeling. However, the molecular mechanism is unclear. PDGF is a potent chemoattractant for SMCs, and TGF‐β regulates SMC differentiation. Here, we examined gene regulation. PDGF‐B stimulation upregulated Ang1 expression in SMCs through the PI3K and PKC pathways. PDGF‐B stimulation also produced an acute induction of TGF‐β expression in SMCs through the MAPK/ERK pathway. Interestingly, TGF‐β negatively regulated Ang1 expression induced by the PDGF‐B stimulation in SMCs. Reciprocally, we observed that stimulation of ECs with either Ang1 or TGF‐β slightly downregulated PDGF expression. A combination of both TGF‐β with Ang1 produced much stronger downregulation of PDGF. Our data showed complex gene regulations that include both positive and negative regulations between ECs and SMCs to maintain vascular homeostasis. © 2003 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here